Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AZ Halts Epanova Study As High Placebo Effect Kills Acasti’s Omega-3 TRILOGY-1 Trial
AZ’s Epanova Hopes Dented, Acasti Focus Turns To Coming TRILOGY-2 Results
Jan 14 2020
•
By
Sten Stovall
Derived from krill oil, Acasti’s CaPre is aimed at treating hypertriglyceridemia • Source: Shutterstock
Have you checked out Scrip podcast?
New episodes every Thursday.
More from Business
More from Scrip